Table 1

Patients‘ characteristics

CharacteristicsPatients with cancer diagnosed:Difference (%)P value
Before lockdown
(March 16, 2019 to
May 31, 2019)
During lockdown
(March 16, 2020 to
May 31, 2020)
Number of patients594342−42%
Age,median (range)61.3 (21–93)59.4 (26–95)0.038*
Patients with distant metastases (FIGO IV or M1)117 (20%)55 (16%)−4%NS†
Patients with early-stage disease (FIGO I or Tis/T1 and N0)284 (48%)133 (39%)−9%NS†
Breast cancer 351201−43%
 Tis34 (10%)17 (8.5%)−1.5%<0.001†
 T1149 (43%)64 (32%)−11%
 T2–4118 (34%)48 (24%)−10%
Tx (due to neoadjuvant chemotherapy)48 (14%)71 (35%)
 N0190 (54%)87 (43%)−11%<0.001†
 N1-3 102 (29%)33 (16%)−13%
 Nx (due to neoadjuvant chemotherapy)59 (17%)81 (40%)
Ovarian cancer 7036−49%
 FIGO I/II19 (27%)9 (25%)−2%NS†
 FIGO III/IV51 (73%)27 (75%)+2%
Endometrial cancer 7751−34%
 FIGO I/II62 (80%)39 (76%)−3%NS†
 FIGO III/IV15 (19%)11 (22%)+3%
Cervical cancer 6433−48%
 FIGO I/II44 (69%)28 (85%)+17%NS†
 FIGO III/IV20 (31%)5 (15%)−17%
Vulvar cancer 199−53%
 FIGO I/II15 (83%)5 (56%)−27%NS†
 FIGO III/IV3 (17%)4 (44%)+27%
Uterine sarcoma 54−20%
Others 880%
  • Characteristics before and after lockdown of all patients and dependent on cancer type.

  • *Mann-Whitney U-test.

  • †χ2 test.

  • NS, non-significant.